Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
150.00    2.80 (1.90%)
Bid:
151.00
Ask:
151.80
Spread: 0.80 (0.53%)
Market Cap: £255.88m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Full year trading update

14 Jul 2022 07:00

RNS Number : 3993S
McBride PLC
14 July 2022
 

14 July 2022

 

McBride plc

 

Full year trading update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides the following trading update for the twelve months ended 30 June 2022.

 

Throughout the year the Group experienced both exceptional input cost inflation and supply chain disruptions, most recently further exacerbated by the Ukraine war. 

 

These impacts have been predominantly offset through pricing actions.

 

As a result, following first half revenue declines of 6.6% on a constant currency basis, revenue grew by 13.4% in the second half to produce Group revenue growth of 2.9% at constant currency for the full year. 

 

The Group anticipates that adjusted operating profit will be in line with current market consensus (*).

 

Net debt, including IFRS 16 leases, closed at circa £168m (30 June 2021: £118.4m). The Group's liquidity at 30 June 2022 was circa £70m, £30m higher than the minimum liquidity requirement of £40m applicable under the Group's financing arrangements.

 

The increase in debt was driven by;

 

· Working capital increases directly resulting from the effects of inflation rolled up in net working capital

· In-year losses

 

The Group continues to explore and assess all avenues to maintain liquidity and create additional funding for the benefit of all stakeholders.

 

We are fully appreciative of the ongoing support that the banking group have and are continuing to give the Group through this period of uncertainty caused by macroeconomic factors which have resulted in rapid and unprecedented rises in input costs and ongoing global supply chain challenges.

 

We expect to announce our year-end results on 29 September 2022.

 

 

(*) Current market consensus refers to full-year Group adjusted operating profit as compiled from broker notes.

 

For further information, please contact:

McBride plc

 

Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Finance Officer

0161 203 7570

FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQXLFFLDLBBBK
Date   Source Headline
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting
25th Aug 20224:40 pmRNSResult of AGM
22nd Aug 20223:41 pmRNSHolding(s) in Company
15th Aug 20225:48 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSNotice of General Meeting
14th Jul 20227:00 amRNSFull year trading update
29th Jun 20227:00 amRNSJune 2022 - Bank Covenant Waiver
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
9th Jun 20221:55 pmRNSDirector/PDMR Shareholding
24th May 20223:20 pmRNSDirector/PDMR Shareholding
23rd May 202212:31 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20221:19 pmRNSDirector/PDMR Shareholding
18th Mar 202210:05 amRNSDirector/PDMR Shareholding
7th Mar 202210:03 amRNSDirector/PDMR Shareholding
28th Feb 20225:47 pmRNSDirector/PDMR Shareholding
24th Feb 20225:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSHalf-year Report
18th Feb 20227:00 amRNSBoard Changes
22nd Dec 20213:02 pmRNSDecember 2021 - Bank Covenant Waiver
16th Dec 20217:00 amRNSFinancial Year 2022 Trading Update
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSRedemption of B Shares
8th Nov 20212:02 pmRNSDirector/PDMR Shareholding
26th Oct 20213:01 pmRNSDirector/PDMR Shareholding
26th Oct 20212:21 pmRNSDirector/PDMR Shareholding
26th Oct 20211:35 pmRNSDirector/PDMR Shareholding
19th Oct 20216:05 pmRNSResult of AGM
19th Oct 20217:00 amRNSAGM Trading Update
7th Oct 20213:05 pmRNSDirector/PDMR Shareholding
5th Oct 20216:21 pmRNSCorrection to the Annual Report
30th Sep 20216:16 pmRNSRedemption of B Shares
24th Sep 20217:00 amRNSAnnual Report 2021 and Annual General Meeting 2021
13th Sep 20213:27 pmRNSDirector/PDMR Shareholding
7th Sep 20214:05 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSFinal Results
2nd Sep 20215:00 pmRNSTransaction in Own Shares
1st Sep 20215:29 pmRNSTransaction in Own Shares
31st Aug 20215:14 pmRNSTransaction in Own Shares
25th Aug 20215:18 pmRNSTransaction in Own Shares
24th Aug 20215:09 pmRNSTransaction in Own Shares
23rd Aug 20215:33 pmRNSTransaction in Own Shares
20th Aug 20215:00 pmRNSTransaction in Own Shares
19th Aug 20215:49 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSFinancial Year 2022 trading update
14th Jul 20217:00 amRNSFull year trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.